Energy expenditure analysis in Duchenne muscular dystrophy in land and aquatic environment
DOI:
https://doi.org/10.34024/rnc.2015.v23.8007Keywords:
Muscular Dystrophy Duchenne, Gait, Energy Metabolism, Aquatic EnvironmentAbstract
Introduction. Duchenne muscular dystrophy (DMD) is a progressive genetic disease, characterized by progressive and irreversible degeneration of muscle fibers, requiring energy demand during functional activities. Given this characteristic, energy expenditure becomes a key factor in a rehabilitation program. So, it is essential energy expenditure clinical assessment in different environments. Objective. Analyze the energy expenditure of children with DMD during gait in aquatic and land environments. Method. The study included 8 boys with DMD (10.4±0.5 years), ambulating and collaborative for testing. They were not included in rehabilitation programs and had no associated diseases. It was applied 6-minute walk test (6MWT) in land and aquatic environment, and calculate energy expenditure index by the formula: End FC - divided by the initial speed FC (meters/ second) and is expressed in beats/minute in the aquatic and terrestrial. Results. It was observed that DMD patients walked (p=0.012) a shorter distance in water in relation to the ground. DMD patients had (p=0.012) higher average of energy expenditure in aquatic environment (3.69±0.44) when compared to land (0.43±0.15). Conclusion. The patients walked a shorter distance and with higher energy expenditure in aquatic environment.
Metrics
References
MacDonald CM. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil 2002;81(11 Suppl):S108-20. http://dx.doi.org/10.1097/01.PHM.0000029767.43578.3C
Tidball J, Wehling-Henricks M. Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events. Pediatr Res 2004;56:831-41. http://dx.doi.org/10.1203/01.PDR.0000145578.01985.D0
Hermans MC, Pinto YM, Merkies ISJ, Die-Smulders CEM, Crijns HJGM, Faber CG. Hereditary muscular dystrophies and the heart. Neuromuscul Disord 2010;20:479-92. http://dx.doi.org/10.1016/j.nmd.2010.04.008
Jansen M, Groot IJM, Geurts ACH, van Alfen NV. Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study. BMC Pediatr 2010;10:5
http://dx.doi.org/10.1186/1471-2431-10-555. Zanardi MC, Tagliabue A, Orcesi S, Berardinelli A, Uggetti C, Pichiecchio A. Body composition and energy expenditure in Duchenne muscular dystrophy. Eur J Clin Nutr 2003;57:273-8. http://dx.doi.org/10.1038/sj.ejcn.1601524
Ribas DIR, Israel VL, Manfra EF, Araújo CC. Estudo comparativo dos parâmetros angulares da marcha humana em ambiente aquático e terrestre em indivíduos hígidos adultos jovens. Rev Bras Med Esporte 2007;13:371-5. http://dx.doi.org/10.1590/S1517-86922007000600003
Souza PV, Fonta HB, Haupenthal A, Schutz GR, Roesler H. Força de reação do solo durante a marcha de crianças em ambiente aquático. Ped Mod 2010;46:146-50.
Barela AMF. Marcha no ambiente aquático. In: Parreira P, Baratella TV. Fisioterapia aquática. São Paulo: Manole, 2011, p51-63.
Britto RR, Souza LAP. Teste de caminhada de seis minutos uma normatização Brasileira. Fisioter Mov 2006; 19:49-54.
Chin T, Sawamura S, Fujita H, Nakajima S, Ojima I, Oyabu H, et al. The efficacy of physiological cost index (PCI) measurement of a subject walking with an Intelligent Prosthesis. Prosthet Orthot Int 1999;23:45-9. http://dx.doi.org/10.3109/03093649909071609
Salmela LFT, Silva PC, Lima RCM, Augusto ACC, Souza AC, Goulart F. Musculação e condicionamento aeróbio na perfomance funcional de hemiplégicos crônicos. Acta Fisiatr 2003;10:54-60. http://dx.doi.org/10.5935/01047795.20030001
Gevaerd MS, Domenech SC, Borges Júnior NG, Higa DF, Lima-Silva AE. Alterações fisiológicas e metabólicas em indivíduo com distrofia muscular de Duchenne durante tratamento fisioterapêutico: um estudo de caso. Fisioter Mov 2010;23:93-103. http://dx.doi.org/10.1590/S0103-51502010000100009
Souza MA, Ferreira ME, Baptista CRDJA, Sverzut ACM. Gait energy expenditure in children with Duchenne muscular dystrophy: case study. Fisioter Pesq 2014;21:193-8. http://dx.doi.org/10.1590/1809-2950/63621022014
Clarke LA, Wraith JE, Beck M, Kolodny EH, Pastores GM, Muenzer J, et al. Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatr 2009;123:229-40. http://dx.doi.org/10.1542/peds.2007-3847
Crapo R, Casaburi R, Coates A, Enright PL, Hankinson JL, Irvin CG,et al. American Thoracic Society: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7. http://dx.doi.org/10.1164/ajrccm.161.1.ats11-99
McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Elfring GL, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010;41:500-10. http://dx.doi.org/10.1002/mus.21544
Mazzone E, Martinelli D, Berardinelli A, Messina S, D’Amico A, Vasco G, et al. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord 2010;20:712-6. http://dx.doi.org/10.1016/j.nmd.2010.06.014
Masumoto K, Mercer JA. Biomechanics of Human Locomotion in Water: An Electromyographic Analysis. Exerc Sport Sci Rev 2008;36:160-9. http://dx.doi.org/10.1097/JES.0b013e31817bfe73
Haupenthal A, Schütz GR, Hubert M, Dabonneville M, Roesler H. Force analysis of the underwater stationary runnig XXV ISBS symposium, 2007, OuroPreto – Brazil.
Caromano F, Themundo Filho MRF, Candeloro JM. Efeitos fisiológicos da imersão e do exercício na água. Rev Fisioter Bra 2003;4:61-6.
Sockolov R, Irwin B, Dressendorfer RH, Bernauer EM. Exercise performance in 6-to-11-year old boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1977;58:195-201.
McDonald CM, Henricson EK, Han JJ, Abresch RT, Nicorici A, Atkinson L, et al. The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations. Muscle Nerve 2010;42:966-74. http://dx.doi.org/10.1002/mus.21808
McDonald CM, Henricson EK, Abresch RT, Florence J, Eagle M, Gappmaier E, et al. The 6-minute walk test and other clinical endpoints in Duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve 2013;48:357- 68. http://dx.doi.org/10.1002/mus.23905
Roesler H, Haupenthal A, Schütz GR, Souza PV. Análise das forças de reação do solo na marcha de adultos a 1,3m de imersão. Fisioter Mov 2005;18:21-31.
